Congestive Heart Failure : Symptoms, Causes and Treatment.

Intro -- CONGESTIVE HEART FAILURE: SYMPTOMS, CAUSES AND TREATMENT -- CONGESTIVE HEART FAILURE: SYMPTOMS, CAUSES AND TREATMENT -- LIBRARY OF CONGRESS CATALOGING-IN-PUBLICATION DATA -- Contents -- Preface -- Chapter 1 MONITORING PULMONARY EDEMA IN CHF PATIENTS WITH A HYBRID BIO-IMPEDANCE APPROACH -- Abstract -- 1. Pulmonary Edema in CHF Patients - Origins and Measuring Techniques -- 2. The Bio-Impedance Approach in Measuring Pulmonary Edema -- 3. A Hybrid Bio-Impedance System for Diagnosing and Monitoring CHF Patients -- 3.1. Technical Design -- 3.1.1. Hardware design -- 3.1.2. Software design -- Lung resistivity estimation -- RR and QT interval calculation -- 3.2. Clinical Results -- 3.2.1. Baseline measurements -- 3.2.2. CHF patients' classification and long-term monitoring -- 3.2.3. Monitoring CHF patients under intravenous diuretics treatment -- 3.2.4. Correlation between bio-impedance measurements and X-ray radiographs -- 3.3. Monitoring CHF Patients at Home Via a Telemedicine Approach -- 4. Summary and Conclusions -- References -- Chapter 2 THE ASSOCIATION BETWEEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SHOCKS AND HEART FAILURE: A REVIEW OF PATHOGENESIS AND MANAGEMENT -- Abstract -- 1. MADIT II and SCD-HeFT: Two Major Randomized Controlled Trials of Implantable Cardioverter-Defibrillator Therapy -- 2. Pathogenesis of Heart Failure in Patients with ICD Shocks -- The Effect of Shock: Appropriate and Inappropriate Shocks -- ICD Shocks and the Activation of Sympathetic Nervous System -- The Activation of Sympathetic Nervous System and the Psychiatric Consequences: Impact on Heart Failure Progression -- Management -- Patient Selection -- Optimal Medical Management of Heart Failure -- Device Programming -- Anti-Arrhythmic Medications, Including Amiodarone -- Management of Psychiatric Symptoms and Syndromes.

Organized Protocol for Review of Patients Receiving ICD Shocks -- Conclusion -- References -- Chapter 3 REVERSIBLE LEFT VENTRICULAR DYSFUNCTION: THE TAKOTSUBO SYNDROME -- Abstract -- Introduction -- Epidemiology -- Aetiology -- Clinical Features -- Diagnosis -- Laboratory Data -- Cardiac Biomarkers -- Stress Hormones -- Electrocardiography -- Echocardiography -- Coronary Angiography and Ventriculography -- Cardiovascular magnetic resonance imaging -- Myocardial Single Photon Emission Computed Tomography -- Endomyocardial Biopsies -- Pathophysiological Mechanisms -- Multivessel Epicardial Coronary Artery Spasm -- Coronary Microvascular Impairment -- Catecholamine Cardiotoxicity -- Therepeutic Options -- Prognosis -- Conclusion -- References -- Chapter 4 OXIDATIVE STRESS AND HEART FAILURE: STILL A VIABLE THERAPEUTIC TARGET? -- Abstract -- Introduction -- Sources of Oxidative Stress in Heart Failure -- Physiological Importance of Redox Signaling -- Implications for Stem Cell Therapy -- Redox-Smart Drug Design for Heart Failure -- Conclusion and Perspectives -- Acknowledgement -- References -- Chapter 5 SIMULATING CALCINEURIN-CENTERED CALCIUM SIGNALING NETWORK IN CARDIAC MYOCYTES -- Abstract -- 1. Introduction -- 2. Methods &amp -- Simulation Results -- 3. Discussions -- 4. Conclusion -- Acknowledgements -- References -- Appendix -- Chapter 6 RIGHT VENTRICULAR FAILURE IN CARDIAC SURGERY -- I. Introduction -- 2. Differences between the RV and LV -- 3. RV Function -- [Negative Intrathoracic Pressure in Early Diastole in the RV] -- Isolated RV model -- Interventricular interaction -- Diastolic Ventricular Interaction -- Systolic Ventricular Interaction -- Effects of LVAD Implantation on RV Function -- RV Afterload -- Effects of Global Ischemia on RV Function -- Treatment Strategy -- Conclusions -- References.

Chapter 7 PLASMA BRAIN NATRIURETIC PEPTIDE - AN INDEPENDENT PREDICTOR OF MORTALITY AND REHOSPITALIZATION IN CONGESTIVE HEART FAILURE - A META-ANALYSIS* -- Abstract -- Background -- Design -- Methods -- Results -- Conclusion -- Introduction -- Material and Methods -- Design -- Literature Search -- Validity Assessment -- Data Abstraction -- Analysis -- Results -- Discussion -- References -- Chapter 8 CONGESTIVE HEART FAILURE: DIFFERENT NON-INVASIVE DIAGNOSIS TECHNIQUES* -- Abstract -- 1. Introduction -- 1.1. Heart Failure -- 1.2. Heart Rate Variability (HRV) -- 2. Material -- 2.1. Data -- 2.2.1. Trial Group -- 2.1.2. Test Group -- 2.2. Pre-processing of RRI Data -- 3. Methods -- 3.1. Method 1: Statistical Signal Characterization -- 3.1.1. Hilbert Transform (HT) -- 3.1.2. Statistical Signal Characterization (SSC) -- 3.2. Method 2: Soft-Decision Wavelet Decomposition -- 3.2.1. Wavelet-decomposition of RRI signal -- 3.2.2. Estimation of Power Spectral Density -- 3.2.3. Implementation on MIT-Trial Data -- 3.3. Receiver Operating Characteristics -- 3.4. Method 3: Pattern Recognition -- 4. Results and Discussion -- 4.1. Results of Method 1: SSC -- 4.1.1. Results of Trial Data -- 4.1.2. Results of Test Data -- 4.1.3. Discussion on SSC results -- 4.1.4. Comparison with Other Studies -- 4.2. Results of Method 2: Soft-Decision Wavelet Decomposition -- 4.2.1. Comparison with FFT-Based Spectral Analysis -- 4.3. Results of Method 3: Pattern Recognition -- 4.3.1. Results on Trial and Test Data -- 4.3.2. Consistency of Results -- 4.3.3. Comparison with Other Techniques -- 5. Conclusion -- References -- Index.

Description based on publisher supplied metadata and other sources.

Electronic reproduction. Ann Arbor, Michigan : ProQuest Ebook Central, 2024. Available via World Wide Web. Access may be limited to ProQuest Ebook Central affiliated libraries.